Saxenda will be offered to adults with non-diabetic hyperglycaemia who have a body mass index (BMI) of at least 35kg per m2 and have a high risk of cardiovascular disease due to risk factors including high blood pressure or high cholesterol levels.
According to NICE, the pre-filled injection pens will be prescribed in secondary care by a specialist multidisciplinary tier 3 weight management service.
Individuals who have been referred to a tier 3 service have usually been offered weight management interventions in a local, intensive lifestyle change programme first…
